New York Medical Center, MBCCOP

The Bronx, New York 10466

0 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma, Non-Hodgkins Lymphoma

Studies at this site

• Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma — Completed
• Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL) — Completed
• Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma — Completed